By: IPP Bureau
Last updated : September 11, 2026 1:56 pm
The unannounced onsite USFDA bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026
Alembic Pharmaceuticals Limited has reported successful completion of United States Food and Drug Administration (USFDA) onsite inspection at its Bioequivalence facility in Vadodara, Gujarat.
As per the company, its bioequivalence facility received no Form 483 observations.
The unannounced onsite USFDA bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026.